Chelate means to capture. Blood chelation therapy was created in the United States, where more than 3,000 practicing physicians help 800,000 patients to benefit annually.
Calcium, cholesterol deposits, and other substances progressively obstruct the arterial lumen, causing it to harden and generating arteriosclerosis, responsible for cardiovascular pathologies, which are the leading cause of death in developed countries.
Therapy involves the slow intravenous administration of ethylenediaminetetraacetic acid (EDTA). The aim is decalcification of the atheromatous plaque and a progressive reduction of arteriosclerosis.
Other effects are:
- Reduction, through entrapment and subsequent urinary elimination, of toxic metals such as lead and mercury.
- Reinstatement of the enzymatic activity of the arterial wall, affected by the toxicity of some metals.
- Reduction of platelet aggregation, an important factor in blood clotting and intravascular thrombi.
Following the indications and protocols of ACAM (American College for Advancement in Medicine), blood chelation is indicated in all those pathologies with compromised circulation, including:
- Coronary disease
- Carotid Artery disease
- Cerebral vascular disease
- Peripheral vascular disease